The preventative medicine problem: nobody wants it

The health care system in America has been set up, thanks to decades of government and private sector incentives, to be all about treatment, not prevention. Now, Merck is feeling the effects of that mindset on preventative care with one of its drugs called Proscar, which has been proven to reduce the risk of prostate cancer. Doctors aren’t prescribing it, according to a new survey. The Proscar dilemma reflects a larger trend in American healthcare — one that Americans will have to confront starting in September.